ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer
European Journal of Cancer
◽
10.1016/j.ejca.2017.01.024
◽
2017
◽
Vol 76
◽
pp. 36-44
◽
Cited By ~ 29
Author(s):
Christophe Massard
◽
Kim Nguyen Chi
◽
Daniel Castellano
◽
Johann de Bono
◽
Gwenaelle Gravis
◽
...
Keyword(s):
Prostate Cancer
◽
Abiraterone Acetate
◽
Dose Finding
◽
Castration Resistant Prostate Cancer
◽
Phase Ib
◽
Castration Resistant
◽
Finding Study
◽
Dose Finding Study
Download Full-text
Related Documents
Cited By
References
Corrigendum to ‘Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer’ [European Journal of Cancer 76 (2017) 36–44]
European Journal of Cancer
◽
10.1016/j.ejca.2017.05.003
◽
2017
◽
Vol 81
◽
pp. 242
◽
Cited By ~ 2
Author(s):
Christophe Massard
◽
Kim Nguyen Chi
◽
Daniel Castellano
◽
Johann de Bono
◽
Gwenaelle Gravis
◽
...
Keyword(s):
Prostate Cancer
◽
Abiraterone Acetate
◽
Dose Finding
◽
Castration Resistant Prostate Cancer
◽
Phase Ib
◽
Castration Resistant
◽
Finding Study
◽
Dose Finding Study
Download Full-text
A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-21-1115
◽
2021
◽
pp. clincanres.1115.2021
Author(s):
Debashis Sarker
◽
Nancy A. Dawson
◽
Ana M. Aparicio
◽
Tanya B Dorff
◽
Allan J. Pantuck
◽
...
Keyword(s):
Prostate Cancer
◽
Phase I
◽
Dose Finding
◽
Castration Resistant Prostate Cancer
◽
Open Label
◽
Castration Resistant
◽
Finding Study
◽
Label Dose
◽
Dose Finding Study
Download Full-text
Phase I, open-label, dose-finding study of GSK2636771, a phosphoinositide 3-kinase (PI3K)β inhibitor, in combination with enzalutamide in male subjects with metastatic castration-resistant prostate cancer (mCRPC)
Annals of Oncology
◽
10.1093/annonc/mdx370.009
◽
2017
◽
Vol 28
◽
pp. v273
◽
Cited By ~ 1
Author(s):
P. Rescigno
◽
J. de Bono
◽
A. Aparicio
◽
S. Chowdhury
◽
P. Twardowski
◽
...
Keyword(s):
Prostate Cancer
◽
Dose Finding
◽
Castration Resistant Prostate Cancer
◽
Open Label
◽
Castration Resistant
◽
Finding Study
◽
Label Dose
◽
Dose Finding Study
◽
Phosphoinositide 3 Kinase
◽
Male Subjects
Download Full-text
Abstract A90: Efficacy and tolerability of cabozantinib at lower dose: A dose finding study in men with castration-resistant prostate cancer and bone metastases.
10.1158/1535-7163.targ-11-a90
◽
2011
◽
Cited By ~ 1
Author(s):
Richard J.B. Lee
◽
M. Dror Michaelson
◽
Philip Saylor
◽
Carol Gurski
◽
Jonathan G. Goldin
◽
...
Keyword(s):
Prostate Cancer
◽
Bone Metastases
◽
Dose Finding
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
◽
Finding Study
◽
Dose Finding Study
Download Full-text
Phase 1 dose-finding study of cabozantinib (cabo) plus abiraterone (abi) combination therapy in castration resistant prostate cancer (CRPC): An investigator-sponsored study.
Journal of Clinical Oncology
◽
10.1200/jco.2014.32.15_suppl.5027
◽
2014
◽
Vol 32
(15_suppl)
◽
pp. 5027-5027
◽
Cited By ~ 9
Author(s):
Christopher Sweeney
◽
Kathryn P. Gray
◽
Lauren Christine Harshman
◽
Aymen Elfiky
◽
Toni K. Choueiri
◽
...
Keyword(s):
Prostate Cancer
◽
Combination Therapy
◽
Phase 1
◽
Dose Finding
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
◽
Finding Study
◽
Dose Finding Study
Download Full-text
2550 Phase Ib study of abiraterone acetate (AA) plus buparlisib (BKM120) or BEZ235 in patients (pts) with castration-resistant prostate cancer (CRPC)
European Journal of Cancer
◽
10.1016/s0959-8049(16)31369-7
◽
2015
◽
Vol 51
◽
pp. S493
Author(s):
K. Chi
◽
D. Castellano
◽
J. De Bono
◽
G. Gravis
◽
L. Dirix
◽
...
Keyword(s):
Prostate Cancer
◽
Abiraterone Acetate
◽
Castration Resistant Prostate Cancer
◽
Phase Ib
◽
Castration Resistant
Download Full-text
A dose finding clinical trial of cabozantinib (XL184) administered in combination with abiraterone acetate in metastatic castration-resistant prostate cancer
The Prostate
◽
10.1002/pros.23662
◽
2018
◽
Vol 78
(14)
◽
pp. 1053-1062
◽
Cited By ~ 3
Author(s):
Atish D. Choudhury
◽
Kathryn P. Gray
◽
Jeffrey G. Supko
◽
Lauren C. Harshman
◽
Mary-Ellen Taplin
◽
...
Keyword(s):
Prostate Cancer
◽
Clinical Trial
◽
Abiraterone Acetate
◽
Dose Finding
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
Download Full-text
Pharmacokinetics, Safety, and Antitumor Effect of Apalutamide with Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer: Phase Ib Study
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-19-3402
◽
2020
◽
Vol 26
(14)
◽
pp. 3517-3524
Author(s):
Edwin M. Posadas
◽
Kim N. Chi
◽
Ronald de Wit
◽
Maja J.A. de Jonge
◽
Gerhardt Attard
◽
...
Keyword(s):
Prostate Cancer
◽
Antitumor Effect
◽
Abiraterone Acetate
◽
Castration Resistant Prostate Cancer
◽
Phase Ib
◽
Castration Resistant
Download Full-text
7024 Phase Ib dose-finding trial of intravenous (i.v.) panobinostat (PAN) with docetaxel (DOC) and prednisone (PRED) in patients (pts) with castration resistant prostate cancer (CRPC)
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(09)71402-8
◽
2009
◽
Vol 7
(2)
◽
pp. 413-414
◽
Cited By ~ 2
Author(s):
U. Vaishampayan
◽
D. Rathkopf
◽
K.N. Chi
◽
S. Hotte
◽
N. Vogelzang
◽
...
Keyword(s):
Prostate Cancer
◽
Dose Finding
◽
Castration Resistant Prostate Cancer
◽
Phase Ib
◽
Castration Resistant
Download Full-text
18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Abiraterone Acetate
Case Medical Research
◽
10.31525/ct1-nct04158245
◽
2019
◽
Author(s):
Keyword(s):
Prostate Cancer
◽
Abiraterone Acetate
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close